Fischer A B, Kumar R, Schröder R. "Method for the Synthesis of Lenacapavir Impurity 31" [P]. US Patent, US 10496841 B2, 2024-06-15.
发明人周伟,张德明,朱建伟. "A Process for Preparing High-Purity Lenacapavir Impurity 31" [P]. 中国发明专利, 专利号 CN 117462316 B, 授权公告日 2019-02-06.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 来那帕韦杂质31 in Pharmaceutical Formulations". J. Chromatogr. A, 2018, 1644, 554-584.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来那帕韦杂质31 as an Impurity". Biomed. Chromatogr., 2025, 1661, (2), 8495-8499.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Lenacapavir Impurity 31 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2016, 597, (11), 2988-3008.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 来那帕韦杂质31 Profile in Drug Substances According to ICH Guidelines". Talanta, 2020, 151, 1827-1851.